Published in Horm Res Paediatr on January 15, 2010
Aromatase inhibitors in pediatrics. Nat Rev Endocrinol (2011) 0.95
Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines. Chem Cent J (2013) 0.75
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron (2003) 6.05
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med (2004) 3.88
Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics (2009) 2.67
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases. Endocr Relat Cancer (2007) 2.63
Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma. J Pathol (2010) 2.17
Follow-up outcomes at 1 and 2 years of infants born less than 32 weeks after Newborn Individualized Developmental Care and Assessment Program. Pediatrics (2009) 2.12
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Miner Res (2007) 1.76
New Dutch reference curves for birthweight by gestational age. Early Hum Dev (2009) 1.73
New data on the late Neandertals: direct dating of the Belgian Spy fossils. Am J Phys Anthropol (2009) 1.73
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol (2002) 1.71
Long-term surveillance of growth hormone therapy. J Clin Endocrinol Metab (2011) 1.64
Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells. J Bone Miner Res (2005) 1.63
Pediatric oncologists' attitudes towards involving adolescents in decision-making concerning research participation. Pediatr Blood Cancer (2010) 1.60
Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. Tissue Eng Part A (2011) 1.50
Associations between prenatal and infancy weight gain and BMI, fat mass, and fat distribution in young adulthood: a prospective cohort study in males and females born very preterm. Am J Clin Nutr (2005) 1.41
Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res (2005) 1.39
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet (2012) 1.34
DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics (2011) 1.33
Stimulation programs for pediatric drug research--do children really benefit? Eur J Pediatr (2007) 1.31
Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng Part A (2012) 1.27
Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab (2005) 1.25
Functional outcomes and participation in young adulthood for very preterm and very low birth weight infants: the Dutch Project on Preterm and Small for Gestational Age Infants at 19 years of age. Pediatrics (2007) 1.25
Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain. J Steroid Biochem Mol Biol (2007) 1.24
Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells. Bone (2003) 1.23
Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res (2005) 1.18
Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences. BMC Med Ethics (2011) 1.16
Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in The Netherlands. Pediatrics (2005) 1.14
Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences. Horm Res (2009) 1.13
A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum (2012) 1.11
Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol (2004) 1.11
Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Mol Pharmacol (2006) 1.09
Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J Clin Endocrinol Metab (2005) 1.08
No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am J Pathol (2010) 1.08
Effects of individualized developmental care in a randomized trial of preterm infants <32 weeks. Pediatrics (2009) 1.08
STAT5b deficiency: lessons from STAT5b gene mutations. Best Pract Res Clin Endocrinol Metab (2011) 1.06
Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation. J Clin Endocrinol Metab (2006) 1.05
The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J Biol Chem (2004) 1.05
The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelines. BMC Pediatr (2008) 1.02
Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Clin Endocrinol (Oxf) (2008) 1.02
Antisense oligodeoxynucleotides for estrogen receptor-beta and alpha attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychopharmacology (2007) 1.02
Diagnostic approach in children with short stature. Horm Res (2009) 1.02
Tissue assembly and organization: developmental mechanisms in microfabricated tissues. Biomaterials (2009) 1.02
Classical androgen receptors in non-classical sites in the brain. Horm Behav (2008) 1.01
Enzyme-catalyzed crosslinkable hydrogels: emerging strategies for tissue engineering. Biomaterials (2011) 1.01
Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats. Nephrol Dial Transplant (2009) 1.01
Two short children born small for gestational age with insulin-like growth factor 1 receptor haploinsufficiency illustrate the heterogeneity of its phenotype. J Clin Endocrinol Metab (2009) 1.01
Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Brain Res Mol Brain Res (2002) 1.00
Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology (2003) 1.00
Estrogen-induced hypothalamic synaptic plasticity and pituitary sensitization in the control of the estrogen-induced gonadotrophin surge. Reprod Sci (2007) 0.99
Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev Biol (2009) 0.99
Micro-CT of corrosion casts for use in the computer-aided design of microvasculature. Tissue Eng Part C Methods (2009) 0.99
Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib. J Clin Oncol (2006) 0.99
An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome. J Clin Endocrinol Metab (2015) 0.99
Chitosan/poly(epsilon-caprolactone) blend scaffolds for cartilage repair. Biomaterials (2010) 0.98
Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int (2007) 0.98
Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol (2010) 0.98
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet (2010) 0.97
Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab (2009) 0.97
Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: perspectives from stem cell biology and molecular medicine. J Cell Physiol (2013) 0.97
Hypoxia inhibits hypertrophic differentiation and endochondral ossification in explanted tibiae. PLoS One (2012) 0.97
How best to define the concept of minimal risk. J Pediatr (2011) 0.96
Catch-up growth: testing the hypothesis of delayed growth plate senescence in humans. J Pediatr (2005) 0.96
The use of bone age in clinical practice - part 1. Horm Res Paediatr (2011) 0.96
Association between head circumference and body size. Horm Res Paediatr (2011) 0.96
Interactions between neuroactive steroids and reelin haploinsufficiency in Purkinje cell survival. Neurobiol Dis (2009) 0.95
Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms. J Endocrinol (2005) 0.95
IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature). Horm Res Paediatr (2012) 0.94
The phenotype of Floating-Harbor syndrome: clinical characterization of 52 individuals with mutations in exon 34 of SRCAP. Orphanet J Rare Dis (2013) 0.93
Neurogenin 3 cellular and subcellular localization in the developing and adult hippocampus. J Comp Neurol (2010) 0.93
Cell sources for articular cartilage repair strategies: shifting from monocultures to cocultures. Tissue Eng Part B Rev (2012) 0.93
Genotype-phenotype correlation in patients suspected of having Sotos syndrome. Horm Res (2004) 0.93
Translocator protein 18 kDa is involved in the regulation of reactive gliosis. Glia (2007) 0.93
High-resolution X-ray microtomography is a sensitive method to detect vascular calcification in living rats with chronic renal failure. Arterioscler Thromb Vasc Biol (2006) 0.92
The effect of platelet lysate supplementation of a dextran-based hydrogel on cartilage formation. Biomaterials (2012) 0.92
Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells. Endocrinology (2006) 0.92
Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. Mol Endocrinol (2004) 0.91
T cell factor 4 is a pro-catabolic and apoptotic factor in human articular chondrocytes by potentiating nuclear factor κB signaling. J Biol Chem (2013) 0.91
An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing. Virchows Arch (2014) 0.91
Estradiol activates beta-catenin dependent transcription in neurons. PLoS One (2009) 0.91
Fibroblast growth factor-1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of osteoarthritic chondrocytes in co-culture. Stem Cells Dev (2013) 0.91
Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. J Pathol (2004) 0.91
Chitosan scaffolds containing hyaluronic acid for cartilage tissue engineering. Tissue Eng Part C Methods (2011) 0.90
Mechanisms of growth plate maturation and epiphyseal fusion. Horm Res Paediatr (2011) 0.90
Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer. Am J Clin Nutr (2007) 0.90
Early motherhood in rats is associated with a modification of hippocampal function. Psychoneuroendocrinology (2007) 0.90
Overgrowth syndromes:from classical to new. Pediatr Endocrinol Rev (2009) 0.90
BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum Mol Genet (2007) 0.90
Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. J Clin Endocrinol Metab (2007) 0.89
Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele. Horm Res (2005) 0.89
Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Invest Ophthalmol Vis Sci (2005) 0.89
Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol (2005) 0.89
Long-term height gain of prematurely born children with neonatal growth restraint: parallellism with the growth pattern of short children born small for gestational age. Pediatrics (2006) 0.89
Recognizing different tissues in human fetal femur cartilage by label-free Raman microspectroscopy. J Biomed Opt (2012) 0.88
17β-estradiol--a new modulator of neuroglobin levels in neurons: role in neuroprotection against H₂O₂-induced toxicity. Neurosignals (2011) 0.88